کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
24749 | 43535 | 2009 | 6 صفحه PDF | دانلود رایگان |
Pituitary tumor-transforming gene 1 (PTTG1), a proto-oncogene, is associated with tumor formation, proliferation and invasiveness. F-PBFβ-TrCP, a fusion protein, was produced by replacing the WD40-repeat of F-box protein β-TrCP with the PTTG1-binding factor (PBF) for targeted degradation of PTTG1. To evaluate the function of F-PBFβ-TrCP, PTTG1-EGFP fusion protein was constructed. Our results showed that F-PBFβ-TrCP can both degrade exogenous PTTG1-EGFP fusion protein in COS-7 cells and endogenous PTTG1 protein in HeLa cells and the targeted PTTG1 knock down resulted in bFGF mRNA level down-regulation and inhibition of proliferation and clonogenicity in HeLa cells. In conclusion, targeted degradation of PTTG1 by F-PBFβ-TrCP has antitumor activity in vitro in HeLa cells. These results suggest that F-PBFβ-TrCP could be used for cancer treatment by targeted degradation of PTTG1.
Journal: Journal of Biotechnology - Volume 139, Issue 1, 1 January 2009, Pages 6–11